Myeloid cells express a plethora of C-type lectin receptors (CLRs) that can regulate immune responses. CLEC-2 belongs to the Dectin-1 sub-family of CLRs that possess an extracellular C-type lectin-like domain and a single intracellular hemITAM motif. CLEC-2 is highly expressed on mouse and human platelets where it signals via Syk to promote aggregation. We generated a monoclonal antibody (mAb) against mouse CLEC-2 and found that CLEC-2 is additionally widely expressed on leukocytes and that its expression is upregulated during inflammation. MAb-mediated crosslinking of CLEC-2 leads to hemI-TAM-dependent signaling via Syk, Ca 21 and NFAT and, in myeloid cells, modulates the effect of toll-like receptor (TLR) agonists to selectively potentiate production of IL-10. A macrophage/dendritic cell-dependent increase in IL-10 is also observed in mice given anti-CLEC-2 mAb together with LPS. Collectively, these data indicate that CLEC-2 is expressed in myeloid cells and acts as a Syk-coupled CLR able to modulate TLR signaling and inflammatory responses.Key words: CLEC-2 . C-type lectin . HemITAM . IL-10 . Syk
Supporting Information available online
IntroductionSignaling by some members of the C-type lectin receptor (CLR) superfamily plays a key role in innate immunity and in regulation of myeloid cell function [1,2]. A classical example is Dectin-1, which is expressed by macrophages (MØs), neutrophils and dendritic cells (DCs) and acts as a pattern recognition receptor for b-glucans present on fungal and some bacterial cell walls. Dectin-1 signals via a phospho-tyrosine-based hemITAM motif in its intracellular domain that recruits spleen tyrosine kinase (Syk) [3,4]. Dectin-1 signaling through Syk in myeloid cells can variably lead to phagocytosis, production of reactive oxygen species (ROS) and/or induction of innate response genes, including those encoding pro-inflammatory cytokines [5,6].
3040Pro-inflammatory Dectin-1 signaling requires CARD9-dependent activation of NF-kB [7] although Dectin-1 can also signal to NF-kB via a Syk-independent pathway [8]. Although many DC types are potently activated by Dectin-1 agonists, in other myeloid cells Dectin-1 signaling only weakly activates the proinflammatory gene program [9]. In those cells, Dectin-1 acts primarily in synergy with other innate immune receptors such as toll-like receptors (TLRs) [10,11]. Notably, both Dectin-1 and CARD9 are important for resistance to fungal infection in both mice [7,12,13] and humans [14,15], indicating the importance of the CLR/Syk signaling pathway in immunity.The features of Dectin-1, including type II membrane topology, single Dectin-1-like C-type lectin-like domain and intracellular hemITAM are shared by two other CLRs, DNGR-1 (CLEC9A) and CLEC-2 (CLEC1B). DNGR-1 is selectively expressed by DCs and acts as a receptor for dead cells, facilitating cross-priming to cell-associated antigens [16]. CLEC-2 was first identified in a screen for natural killer (NK) cell receptors and its mRNA was found in myeloid cells and in some NK-cell clones [...